Genetic Medicines to Treat Cardiovascular Disease
Published in Chemistry, Cell & Molecular Biology, and Genetics & Genomics
Important Deadlines
Early Registration Deadline: November 24, 2026
Scholarship Deadline: September 30, 2026
Short Talk Abstract Deadline: September 30, 2026
Poster Abstract Deadline: January 4, 2027
Meeting Summary
Title: Genetic Medicines to Treat Cardiovascular Disease
Date: January 25 - 28, 2027
Location: Keystone Resort, Keystone, CO, USA
Scientific Organizers: Rick Dewey, Litsa G. Kranias, and James S. Ware
Keynote Speaker(s): Sekar Kathiresan, Verve Therapeutics
Genetic medicines are transforming how we treat cardiovascular disease, unlocking opportunities to correct heart and vascular disorders in ways once thought impossible. Basic scientists, clinicians, industry leaders, and innovators will convene at Genetic Medicines to Treat Cardiovascular Disease to explore how gene therapy, RNA-based approaches, gene editing, and advanced disease models are driving these breakthroughs.
The program blends cutting-edge science and real-world translation. Sessions will highlight advances in mechanisms underlying cardiovascular genetics, therapeutic target identification, and novel delivery technologies. Plenary speakers and abstract-selected talks will connect foundational research with translational strategies, offering attendees a holistic view of where the field is headed.
Additionally, the program will feature panel discussions focused on the steps leading from basic discovery to translation, commercialization, FDA approval, and navigating the venture capital landscape. Key topics include challenges and opportunities in delivery, efficacy, safety, trial design, long-term and off-target effects of therapies, and ethical and regulatory considerations. The program also includes lessons from preclinical and clinical trials, and professional development challenges for early-career researchers.
This meeting also emphasizes interdisciplinary collaboration and career development. Career roundtables provide trainees and early-career investigators with direct access to leaders from academia, biotech, and industry for guidance on scientific and professional growth.
Join Options
Attend in person or catch sessions on demand after the conclusion of the conference.
*Keystone Symposia Scholarships & Awards*
Keystone Symposia offers discounted registration to students in undergraduate, M.S., Ph.D., or M.D. programs, providing access to the latest scientific advances, technologies, and approaches to further research and careers.
In addition, several financial aid opportunities are also available to support attendance at its scientific meetings:
- Student and Postdoctoral Scholarships provide up to $1,200 to help defray travel, lodging, registration, and related costs when presenting a poster at an in-person conference. Awards are competitive, based on the abstract’s scientific quality and relevance, and you must apply by the individual scholarship deadline for the desired meeting (abstract + mentor letter required).
- Early-Career Travel Awards (ECITAs) support early-career investigators with funding to attend meetings; these also require application by the posted deadline for each conference.
- Global Health Travel Awards (GHTAs) provide financial aid for scientists, clinicians, fellows, and students from low- and middle-income countries (LMICs) to participate in select Keystone Symposia meetings, especially those focused on global health topics. These awards may cover registration, lodging, airfare, and ground transportation, and applications are submitted through the Financial Aid Portal by the listed meeting deadlines. Learn which meetings have in-person GHTAs available: https://www.keystonesymposia.org/financial-aid/global-health-awards/ghta-listing
For details on eligibility, deadlines, and how to apply for financial aid, visit: https://www.keystonesymposia.org/financial-aid.
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in